Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-17-026986
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-20 16:55:18
Reporting Period:
2017-11-16
Accepted Time:
2017-11-20 16:55:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1465837 Boxer Capital, Llc 11682 El Camino Real, Suite 320
San Diego CA 92130
No No Yes No
1642355 Ltd. Braslyn C/o Cay House P.o. Box N-7776
E.p. Taylor Drive Lyford Cay
New Providence C5
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-16 144,736 $13.00 1,372,510 No 4 P Direct
Common Stock Acquisiton 2017-11-16 255,264 $13.00 3,135,966 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (right to purchase) Acquisiton 2017-11-16 801,448 $13.00 801,448 $0.00
Common Stock Warrant (right to purchase) Acquisiton 2017-11-16 1,413,475 $13.00 1,413,475 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
801,448 2017-11-16 No 4 P Direct
1,413,475 2017-11-16 No 4 P Direct
Footnotes
  1. These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. ("Braslyn"), (ii) Boxer Capital, (iii) Boxer Asset Management Inc. ("Boxer Management"), (v) MVA Investors, LLC ("MVA Investors"), (vi) Joseph C. Lewis, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) Neil Reisman, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang (collectively, the "Boxer Group), and indirectly by Boxer Management and Messrs. Lewis, Fuglesang, Reisman, Lieberburg, Dissanayake, and Davis, by virtue of their ownership in Boxer Capital. Each of Messrs. Fuglesang, Reisman, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interes
  2. These securities are owned directly by Braslyn, which may be deemed to be a member of the Boxer Group. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn.
  3. The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock.